-
3
-
-
80155183703
-
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
-
Amato L., Minozzi S., Davoli M., Vecchi S. (2011): Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev (10): CD004147.
-
(2011)
Cochrane Database Syst Rev
, vol.10
-
-
Amato, L.1
Minozzi, S.2
Davoli, M.3
Vecchi, S.4
-
4
-
-
77957265696
-
-
Australian Government, Therapeutic Goods Administration, Australian Public Assessment Report for Buprenorphine/ Naloxone. TGA health safety Regulation
-
Australian Government, Department of Health and Ageing, Therapeutic Goods Administration (2011): Australian Public Assessment Report for Buprenorphine/ Naloxone. TGA health safety Regulation, http://www.tga.gov.au/pdf/auspar/auspar-suboxone.pdf.
-
(2011)
Department of Health and Ageing
-
-
-
5
-
-
4644227528
-
A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence
-
Bell J., Byron G., Gibson A., Morris A. (2004): A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence. Drug Alcohol Rev. 23(3): 311-317.
-
(2004)
Drug Alcohol Rev
, vol.23
, Issue.3
, pp. 311-317
-
-
Bell, J.1
Byron, G.2
Gibson, A.3
Morris, A.4
-
6
-
-
84995255600
-
Philosophy and reality in methadone treatment
-
Desjarleis D. C. (1994): Philosophy and reality in methadone treatment. Addiction: 807-809.
-
(1994)
Addiction
, pp. 807-809
-
-
Desjarleis, D.C.1
-
7
-
-
27544457547
-
A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride
-
Dole V. P., Nyswander M. E. (1965): A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride. JAMA. 193: 80-84.
-
(1965)
JAMA
, vol.193
, pp. 80-84
-
-
Dole, V.P.1
Nyswander, M.E.2
-
8
-
-
84880166175
-
-
Europad
-
Europad (2013): Conclusions endorsed at the plenary session of May 27, 2012 during the 10th European Congress of the European Opiate Addiction Treatment Association, Barcelona, Spain, EU, May 25-27, 2012. Heroin Addict Relat Clin Probl. 15(1): 14.
-
(2013)
Conclusions Endorsed At the Plenary session of May 27, 2012 During the 10th European Congress of the European Opiate Addiction Treatment Association, Barcelona, Spain, EU, May 25-27, 2012. Heroin Addict Relat Clin Probl
, vol.15
, Issue.1
, pp. 14
-
-
-
9
-
-
0242556465
-
Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroindependent volunteers
-
Greenwald M. K., Johanson C. E., Moody D. E., Woods J. H., Kilbourn M. R., Koeppe R. A., Schuster C. R., Zubieta J. K. (2003): Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroindependent volunteers. Neuropsychopharmacology. 28(11): 2000-2009.
-
(2003)
Neuropsychopharmacology
, vol.28
, Issue.11
, pp. 2000-2009
-
-
Greenwald, M.K.1
Johanson, C.E.2
Moody, D.E.3
Woods, J.H.4
Kilbourn, M.R.5
Koeppe, R.A.6
Schuster, C.R.7
Zubieta, J.K.8
-
10
-
-
84880170966
-
-
Centre for Addiction and Mental Health endorsed by College of Family Physicians of Canada, Toronto, Canada
-
Handford C., Kahan M., Srivastava A., Cirone S., Sanghera S., Palda V., Lester M. D., Janecek E., Franklyn M., Cord M., Selby P., Ordean A. (2011): Buprenorphine/ Naloxone for Opioid Dependence: Clinical Practice Guideline. Centre for Addiction and Mental Health endorsed by College of Family Physicians of Canada, Toronto, Canada.
-
(2011)
Buprenorphine/ Naloxone For Opioid Dependence: Clinical Practice Guideline
-
-
Handford, C.1
Kahan, M.2
Srivastava, A.3
Cirone, S.4
Sanghera, S.5
Palda, V.6
Lester, M.D.7
Janecek, E.8
Franklyn, M.9
Cord, M.10
Selby, P.11
Ordean, A.12
-
11
-
-
39149109712
-
Case management for persons with substance use disorders
-
Hesse M., Vanderplasschen W., Rapp R. C., Broekaert E., Fridell M. (2007): Case management for persons with substance use disorders. Cochrane Database Syst Rev(4): CD006265.
-
(2007)
Cochrane Database Syst Rev
, vol.4
-
-
Hesse, M.1
Vanderplasschen, W.2
Rapp, R.C.3
Broekaert, E.4
Fridell, M.5
-
12
-
-
34249338734
-
A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial
-
Kakko J., Gronbladh L., Svanborg K. D., Von Wachenfeldt J., Ruck C., Rawlings B., Nilsson L. H., Heilig M. (2007): A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 164(5): 797-803.
-
(2007)
Am J Psychiatry
, vol.164
, Issue.5
, pp. 797-803
-
-
Kakko, J.1
Gronbladh, L.2
Svanborg, K.D.3
von Wachenfeldt, J.4
Ruck, C.5
Rawlings, B.6
Nilsson, L.H.7
Heilig, M.8
-
13
-
-
0033679983
-
Opioid receptor imaging with PET and [18F]cyclofoxy in long-term methadone-treated former heroin addicts
-
Kling M. A., Carson R. E., Borg L., Zametkin A., Matochik J. A., Schluger J., Herscovitch P., Rice K. C., Ho A., Eckelman W. C., Kreek M. J. (2000): Opioid receptor imaging with PET and [18F]cyclofoxy in long-term methadone-treated former heroin addicts. J Pharmacol Exp Ther. 295: 1070-1076.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 1070-1076
-
-
Kling, M.A.1
Carson, R.E.2
Borg, L.3
Zametkin, A.4
Matochik, J.A.5
Schluger, J.6
Herscovitch, P.7
Rice, K.C.8
Ho, A.9
Eckelman, W.C.10
Kreek, M.J.11
-
14
-
-
56049124615
-
When a New Drug Promotes the Integration of Treatment Modalities: Suboxone and Harm Reduction
-
Maremmani I. (2008): When a New Drug Promotes the Integration of Treatment Modalities: Suboxone and Harm Reduction. Heroin Addict Relat Clin Probl. 10(3): 5-12.
-
(2008)
Heroin Addict Relat Clin Probl
, vol.10
, Issue.3
, pp. 5-12
-
-
Maremmani, I.1
-
15
-
-
84880154349
-
Heroin Dependence: Theory of Different Levels of Intervention
-
In: Maremmani I. (Ed.), Pacini Editore Medicina, Pisa
-
Maremmani I. (2009): Heroin Dependence: Theory of Different Levels of Intervention. In: Maremmani I. (Ed.) The Principles and Practice of Methadone Treatment. Pacini Editore Medicina, Pisa. pp. 31-38.
-
(2009)
The Principles and Practice of Methadone Treatment
, pp. 31-38
-
-
Maremmani, I.1
-
19
-
-
56049094331
-
Harm reduction and specific treatments for heroin addiction. Different approaches or levels of intervention?. An illness-centred perspective
-
Maremmani I., Pacini M., Lubrano S., Giuntoli G., Lovrecic M. (2002): Harm reduction and specific treatments for heroin addiction. Different approaches or levels of intervention?. An illness-centred perspective. Heroin Addict Relat Clin Probl. 4(3): 5-11.
-
(2002)
Heroin Addict Relat Clin Probl
, vol.4
, Issue.3
, pp. 5-11
-
-
Maremmani, I.1
Pacini, M.2
Lubrano, S.3
Giuntoli, G.4
Lovrecic, M.5
-
20
-
-
77950673943
-
Subtyping Patients with Heroin Addiction at Treatment Entry: Factors Derived fron the SCL-90
-
Maremmani I., Pani P. P., Pacini M., Bizzarri J. V., Trogu E., Maremmani A. G. I., Perugi G., Gerra G., Dell'osso L. (2010): Subtyping Patients with Heroin Addiction at Treatment Entry: Factors Derived fron the SCL-90. Ann Gen Psychiatry. 9(1): 15.
-
(2010)
Ann Gen Psychiatry
, vol.9
, Issue.1
, pp. 15
-
-
Maremmani, I.1
Pani, P.P.2
Pacini, M.3
Bizzarri, J.V.4
Trogu, E.5
Maremmani, A.G.I.6
Perugi, G.7
Gerra, G.8
Dell'osso, L.9
-
21
-
-
44949167587
-
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
-
Mattick R. P., Kimber J., Breen C., Davoli M. (2008): Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev(2): CD002207.
-
(2008)
Cochrane Database Syst Rev
, vol.2
-
-
Mattick, R.P.1
Kimber, J.2
Breen, C.3
Davoli, M.4
-
22
-
-
0027407494
-
The effects of psychosocial services in substance abuse treatment
-
Mclellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'brien C. P. (1993): The effects of psychosocial services in substance abuse treatment. JAMA. 269(15): 1953-1959.
-
(1993)
JAMA
, vol.269
, Issue.15
, pp. 1953-1959
-
-
McLellan, A.T.1
Arndt, I.O.2
Metzger, D.S.3
Woody, G.E.4
O'Brien, C.P.5
-
23
-
-
84876984133
-
The effects of a novel take-home treatment strategy in patients with opioid-dependence receiving long-term opioid replacement therapy with buprenorphine/naloxone in Italy: A cost analysis
-
Montesano F., Mellace V., On Behalf of Atc-Dpc Project Group (2013): The effects of a novel take-home treatment strategy in patients with opioid-dependence receiving long-term opioid replacement therapy with buprenorphine/naloxone in Italy: A cost analysis. Heroin Addict Relat Clin Probl. 15(1): 45-52.
-
Heroin Addict Relat Clin Probl
, vol.15
, Issue.1
, pp. 45-52
-
-
Montesano, F.1
Mellace, V.2
-
24
-
-
84880142436
-
Methadone and buprenorphine for the management of opioid dependence
-
National Institute for Health and Clinical Excellence
-
National Institute for Health and Clinical Excellence (2010): Methadone and buprenorphine for the management of opioid dependence. NHS, http://www.nice.org.uk/nicemedia/pdf/TA114Niceguidance.pdf.
-
(2010)
NHS
-
-
-
25
-
-
0003300292
-
The Pharmacological Rationale for Methadone Treatment of Narcotic Addiction
-
In: Tagliamonte A., Maremmani I. (Eds.), Springer-Verlag, Wien New York
-
Newman R. G. (1995): The Pharmacological Rationale for Methadone Treatment of Narcotic Addiction. In: Tagliamonte A., Maremmani I. (Eds.): Drug Addiction and Related Clinical Problems. Springer-Verlag, Wien New York. pp. 109-118.
-
(1995)
Drug Addiction and Related Clinical Problems
, pp. 109-118
-
-
Newman, R.G.1
-
26
-
-
56049100243
-
Starring Harm Reduction (Editorial)
-
O'hare P. (1994): Starring Harm Reduction (Editorial). Int J Drug Policy. 5: 199-200.
-
(1994)
Int J Drug Policy
, vol.5
, pp. 199-200
-
-
O'Hare, P.1
-
29
-
-
78049235506
-
The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment
-
Pinto H., Maskrey V., Swift L., Rumball D., Wagle A., Holland R. (2010): The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abuse Treat. 39(4): 340-352.
-
(2010)
J Subst Abuse Treat
, vol.39
, Issue.4
, pp. 340-352
-
-
Pinto, H.1
Maskrey, V.2
Swift, L.3
Rumball, D.4
Wagle, A.5
Holland, R.6
-
30
-
-
84880174321
-
-
Presidenza Del Consiglio Dei Ministri, L'integrazione M. P. L. C. I. E., Dipartimento Poliche Antidroga (2012): Relazione annuale al parlamento 2012. Sull'uso di sostanze stupefacenti e sulle tossicodipendenze in Italia. dati relativi all'anno 2011 e primo semestre 2012 - Elaborazioni 2012. Sintesi. Italian Government, accessed 2013/05/11
-
Presidenza Del Consiglio Dei Ministri, L'integrazione M. P. L. C. I. E., Dipartimento Poliche Antidroga (2012): Relazione annuale al parlamento 2012. Sull'uso di sostanze stupefacenti e sulle tossicodipendenze in Italia. dati relativi all'anno 2011 e primo semestre 2012 - Elaborazioni 2012. Sintesi. Italian Government, http://www.politicheantidroga.it/media/569861/filecumulativo_light.pdf (accessed 2013/05/11).
-
-
-
-
31
-
-
84880174041
-
-
Rand Europe, Ernst & Young Llp, University of Cambridge, National evaluation of the Department of Health's integrated care pilots. RAND Europe, Cambridge
-
Rand Europe, Ernst & Young Llp, University of Cambridge (2012): National evaluation of the Department of Health's integrated care pilots. RAND Europe, Cambridge.
-
(2012)
-
-
-
32
-
-
77952118055
-
-
Rb Pharmaceuticals Limited, Available at: wwwemaeuropaeu. Accessed on 16 February 2011
-
Rb Pharmaceuticals Limited (2011): Suboxone summary of product characteristics. Available at: wwwemaeuropaeu. Accessed on 16 February 2011.
-
(2011)
Suboxone Summary of Product Characteristics
-
-
-
33
-
-
84880141237
-
-
Scottish Medicines Consortium, buprenorphine/ naloxone 2mg/0.5mg, 8/2mg sublingual tablet (Suboxone). NHS,
-
Scottish Medicines Consortium (2007): buprenorphine/ naloxone 2mg/0.5mg, 8/2mg sublingual tablet (Suboxone). NHS, http://www.scottishmedicines.org.uk/files/buprenorphine_naloxone_sublingual_tablet__Suboxone__355-07_.pdf.
-
(2007)
-
-
-
34
-
-
84995219008
-
Methadone Maintenance Treatment: Harm reduction or rehabilitation?
-
Wells B. (1994): Methadone Maintenance Treatment: harm reduction or rehabilitation? Addiction. 89: 806.
-
(1994)
Addiction
, vol.89
, pp. 806
-
-
Wells, B.1
|